Quitting smoking during substance use disorders treatment: Patient and treatment-related variables.
Quitting smoking during substance use disorders treatment: Patient and treatment-related variables.
复制标题
DOI：
10.1016/j.jsat.2016.11.002
复制
发表时间：
2017-02
影响因子：
3.9
通讯作者：
Guydish, Joseph
中科院分区：
文献类型：
--
作者：
Campbell, Barbara K.;Le, Thao;Tajima, Barbara;Guydish, Joseph
虽然接受药物使用障碍治疗的个人吸烟率仍然很高，但正在实施促进戒烟的法规、政策和方案改革，一些患者成功戒烟。我们研究了吸烟模式、烟草广告接受度、反烟草信息意识、健康风险认知、对解决吸烟问题的态度以及戒烟服务的可用性与SUD治疗期间戒烟的关系。调查由从国家药物滥用治疗临床试验网络内公共资助的成人治疗项目中随机选择的24个项目中的1127名患者完成，并按项目类型（住院、美沙酮维持、门诊）分层。在接受SUD治疗至少一个月的受访者中，有631名当前吸烟者和52名在调查完成前至少一个月在治疗期间戒烟的前吸烟者;这些受访者组成了我们的样本（N=683）。结果显示，报告健康问题作为戒烟原因的参与者在治疗期间戒烟的可能性是报告健康问题影响戒烟的参与者的1.27倍（p= 0.015）。此外，在SUD治疗期间报告戒烟是其个人治疗计划的一部分的参与者在治疗期间戒烟的可能性是1.08倍（p<.001）。美沙酮治疗参与者在治疗期间报告成功戒烟的可能性比门诊治疗参与者低49%（95%CI：0. 05）。35-0.75，p<.001）。利用对吸烟的健康担忧，并将戒烟纳入个性化治疗计划中，可能有助于在SUD治疗期间增加戒烟。
Although individuals in substance use disorders (SUD) treatment continue to smoke at high rates, regulatory, policy and programming changes promoting tobacco cessation are being implemented and some patients quit successfully. We examined associations of smoking patterns, tobacco advertising receptivity, anti-tobacco message awareness, health risk perception, attitudes towards addressing smoking and availability of smoking cessation services with quitting smoking during SUD treatment. Surveys were completed by 1127 patients in 24 programs chosen randomly, stratified by program type (residential, methadone maintenance, outpatient), from among publicly funded, adult treatment programs within the National Drug Abuse Treatment Clinical Trials Network. Among respondents who had been in SUD treatment for at least one month, there were 631 current smokers and 52 former smokers who reported quitting smoking during treatment for at least one month prior to survey completion; these respondents comprised our sample (N=683). Results showed that participants who reported health concerns as a reason for quitting were 1.27 times more likely to have quit during treatment (p=.015) than those reporting health concerns affected quitting a little or not at all. Additionally, participants who reported that smoking cessation was part of their personal treatment plan during SUD treatment were 1.08 times more likely to have quit during treatment (p<.001). Participants in methadone treatment were 49% less likely to report successfully quitting during treatment than those in outpatient treatment (95%CI: 0. 35-0.75, p<.001). Leveraging health concerns about smoking and including smoking cessation in an individualized treatment plan may help increase smoking cessation during SUD treatment.
登录
查看更多内容
影响因子：
4.2
作者：
Guydish, Joseph;Tajima, Barbara;Ziedonis, Doug
通讯作者：
Ziedonis, Doug
影响因子：
12.7
作者：
Gilpin, Elizabeth A.;White, Martha M.;Pierce, John P.
通讯作者：
Pierce, John P.
影响因子：
5.1
作者：
Halpern-Felsher, BL;Biehl, M;Rubinstein, ML
通讯作者：
Rubinstein, ML
影响因子：
6
作者：
Chandola, T;Head, J;Bartley, M
通讯作者：
Bartley, M
影响因子：
6
作者：
Baker, Timothy B.;Collins, Linda M.;Fiore, Michael C.
通讯作者：
Fiore, Michael C.